Showing results (331-340 of 354) with videos related to

Sort By:
Pageof 36
Journal of the American Geriatrics Society|December 11, 2021
Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A StudySergio Salmerón Ríos, Elisa Belén Cortés Zamora, Almudena Avendaño Céspedes, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatmentAntonino Glaviano, Seth A Wander, Richard D Baird, et al.
EMBO Molecular Medicine|May 31, 2020
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patientsJustin Stebbing, Venkatesh Krishnan, Stephanie de Bono, et al.
Oncogene|November 28, 2018
The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic interventionAlexander Renziehausen, Hexiao Wang, Bhavya Rao, et al.
Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.
Respiratory Research|April 2, 2024
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDSIoannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, et al.
British Journal of Cancer|September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
Journal of the American Geriatrics Society|July 8, 2021
Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumoniaPedro Abizanda, Juan María Calbo Mayo, Marta Mas Romero, et al.
Oncogene|December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Oncogene|November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Pageof 36